These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37781768)

  • 1. Efficacy and safety of agomelatine versus SSRIs/SNRIs for post-stroke depression: a systematic review and meta-analysis of randomized controlled trials.
    Chen Y; Li J; Liao M; He Y; Dang C; Yu J; Xing S; Zeng J
    Int Clin Psychopharmacol; 2024 May; 39(3):163-173. PubMed ID: 37781768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
    Machado M; Iskedjian M; Ruiz I; Einarson TR
    Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy and safety of Jiedu Tongluo granules for treating post-stroke depression with qi deficiency and blood stasis syndrome: study protocol for a randomized controlled trial.
    Zhao AM; Qiu WR; Mao LJ; Ren JG; Xu L; Yao MJ; Bilinksi K; Chang D; Liu JX
    Trials; 2018 May; 19(1):275. PubMed ID: 29747670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of SSRIs and SNRIs in major depressive disorder: a meta-analysis of head-to-head randomized clinical trials.
    Machado M; Einarson TR
    J Clin Pharm Ther; 2010 Apr; 35(2):177-88. PubMed ID: 20456736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agomelatine versus other antidepressive agents for major depression.
    Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and safety of agomelatine, sertraline, and escitalopram for senile post-stroke depression: A randomized double-blind placebo-controlled trial.
    Yao XW; Li YL; Yu ZJ; Mo CY; Pan HS; Li CY
    Clin Neurol Neurosurg; 2021 Apr; 205():106651. PubMed ID: 33940563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
    Demyttenaere K; Corruble E; Hale A; Quera-Salva MA; Picarel-Blanchot F; Kasper S
    CNS Spectr; 2013 Jun; 18(3):163-70. PubMed ID: 23472671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of low-frequency rTMS combined with antidepressants on depression in patients with post-stroke depression: a systematic review and meta-analysis.
    Pan J; Li H; Wang Y; Lu L; Wang Y; Zhao T; Zhang D; Jin S
    Front Neurol; 2023; 14():1168333. PubMed ID: 37273720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin and agomelatine for preventing seasonal affective disorder.
    Nussbaumer-Streit B; Greenblatt A; Kaminski-Hartenthaler A; Van Noord MG; Forneris CA; Morgan LC; Gaynes BN; Wipplinger J; Lux LJ; Winkler D; Gartlehner G
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD011271. PubMed ID: 31206585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM; Gao KR; Yu H; Shen YF; Li HF
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vortioxetine for depression in adults.
    Koesters M; Ostuzzi G; Guaiana G; Breilmann J; Barbui C
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD011520. PubMed ID: 28677828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant efficacy of agomelatine versus SSRI/SNRI: results from a pooled analysis of head-to-head studies without a placebo control.
    Kasper S; Corruble E; Hale A; Lemoine P; Montgomery SA; Quera-Salva MA
    Int Clin Psychopharmacol; 2013 Jan; 28(1):12-9. PubMed ID: 23023074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Chaihu Jia Longgu Muli Decoction in the Treatment of Poststroke Depression: A Systematic Review and Meta-Analysis.
    Wan R; Song R; Fan Y; Li L; Zhang J; Zhang B; Li X; Wang S
    Evid Based Complement Alternat Med; 2021; 2021():7604537. PubMed ID: 34457030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials.
    Wu T; Yue T; Yang P; Jia Y
    J Ethnopharmacol; 2022 Aug; 294():115367. PubMed ID: 35562090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials.
    Kong W; Deng H; Wan J; Zhou Y; Zhou Y; Song B; Wang X
    Front Pharmacol; 2020; 11():580858. PubMed ID: 33343351
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
    Mead GE; Hsieh CF; Lee R; Kutlubaev MA; Claxton A; Hankey GJ; Hackett ML
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD009286. PubMed ID: 23152272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.